FDA product code PWD: Flow Cytometric Test System For Hematopoietic Neoplasms
PWD is the FDA product code for flow cytometric test system for hematopoietic neoplasms. It is a Class II device, regulated under 21 CFR 864.7010 and reviewed by the Hematology panel. FDA has cleared 2 510(k) submissions under PWD, 1 in the last five years, from 2 different applicants. The average 510(k) review took 180 days (median 180); 270 days on average over the last three years. 1 De Novo request was granted under it.
Definition
Reagents intended for in vitro diagnostic use as a panel for qualitative identification of cell populations by multiparameter immunophenotyping on a flow cytometer. These reagents are used as an aid in the differential diagnosis of hematologically abnormal patients having, or suspected of having the following hematopoietic neoplasms: chronic leukemia, acute leukemia, non-Hodgkin's lymphoma, myeloma, myelodysplastic syndrome (MDS), and/or myeloproliferative neoplasms (MPN)
Classification
| Field | Value |
|---|---|
| Device name | Flow Cytometric Test System For Hematopoietic Neoplasms |
| Device class | Class II |
| Regulation | 21 CFR 864.7010 |
| Review panel | HE — Hematology |
| Medical specialty | Hematology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for PWD
| Year | Clearances | Avg. review days |
|---|---|---|
| 2019 | 1 | 90 |
| 2026 | 1 | 270 |
Compare with all 510(k) review times · Search every PWD clearance
Top PWD applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Bd Biosciences | 1 | 2026-10-20 |
| Beckman Coulter | 1 | 2019-03-21 |
Most recent PWD clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K260215 | Bd Biosciences | BD OneFlow LST; BD OneFlow B-CLPD T1; BD FACSLyric Flow Cytometer, 8-color [4-2-2], 10-color [4-3-3], 12-color (4-3-5) | 2026-10-20 | 270 |
| K183592 | Beckman Coulter | ClearLLab 10C Panels (B, T, M1, M2), Navios Flow Cytometer, Navios EX Flow Cytometer | 2019-03-21 | 90 |
Recalls for PWD devices
FDA recall records list no recalls for product code PWD.
Frequently asked questions
What is FDA product code PWD?
PWD is the FDA product code for flow cytometric test system for hematopoietic neoplasms. It is a Class II device, regulated under 21 CFR 864.7010 and reviewed by the Hematology panel.
What device class is PWD?
Class II, regulation 21 CFR 864.7010. Typical premarket route: 510(k).
How long does a 510(k) take for product code PWD?
Across 2 cleared submissions the average was 180 days from receipt to decision (median 180).
Which companies have the most PWD clearances?
Bd Biosciences (1); Beckman Coulter (1).
Next steps
- Run an FDA pathway report with predicate devices for product code PWD
- Run a recall and safety report across every PWD manufacturer
- Watch product code PWD for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times